Navigation Links
ValGenesis, Inc. Achieves SSAE 16 SOC 2 Type 1 Audit Certification
Date:8/22/2013

FREMONT, Calif., Aug. 22, 2013 /PRNewswire/ -- ValGenesis Inc., the market leader in enterprise Validation Management Software solutions, today announced that the company has successfully completed a Service Organization Control 2 (SOC 2) Type 1 certification under AT Section 101.  Completion of the SOC 2 Type I certification indicates that processes, procedures and controls adopted by ValGenesis Inc. in their validated private cloud have been formally evaluated and tested by an independent accounting and auditing firm.  The certification included the company's controls related to the Trust Services Principles and Criteria of Security and Availability.

Hosted ValGenesis Validation Lifecycle Management System (VLMS), through its validated private cloud, allows companies of any size to manage their Validation Lifecycle, Risk and Change management processes, as a 100% paperless process, with built-in best practices. Organizations with certification and compliance requirements such as FDA, EMA and HIPAA etc. may request and leverage the ValGenesis SOC 2 Type I report as part of their compliance strategy.

"SOC 2 exams are rigorous independent assessments, geared toward technology service providers, especially providers of hosting solutions to regulated manufacturing companies," said Siva Samy, Chief Product Strategist, ValGenesis, Inc. "With our successful completion of certification, we are able to provide our customers with greater insights into our controls, procedures and systems for our hosting solution."

This certification is also an important step for any Software-as-a-Service (SaaS) provider that supports outsourced, mission-critical, and information technology services. The audit includes a full assessment of:

  • Security: Data centers are protected against unauthorized access (both physical and logical).
  • Availability: Data centers are available for operation and use as committed or agreed.

A SOC 2 examination is widely recognized, because it represents that a service organization has been through an evaluation of their control activities as they relate to the applicable Trust Services Principles and Criteria.

About ValGenesis

ValGenesis, Inc. is the leading provider of an innovative software platform designed to provide the foundation for compliance-based validation activities in Life Sciences companies. ValGenesis provides the first Enterprise application to manage the corporate validation lifecycle process. Through an industry peer review committee, the Parenteral Drug Association (PDA) recognized the ValGenesis solution with its very prestigious New Innovative Technology award. The ValGenesis Suite is designed to be fully compliant with FDA 21 CFR Part 11 requirements. For more information, visit the ValGenesis website at http://www.valgenesis.com.

Media Contact:

Mike Beaudro
Marketing Manager
ValGenesis, Inc
47102 Mission Falls Court
Fremont, CA 94539
Ph: 510 445 0505

Read more news from ValGenesis Inc.


'/>"/>
SOURCE ValGenesis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Luminex Corporation Achieves Milestone, Ships 10,000th Instrument
2. Heptares Achieves First Research Milestone in Research Collaboration with Cubist
3. MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy
4. Top-line Data Show AcelRx Pharmaceuticals ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial
5. Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study
6. Relievant Medsystems Achieves Completion of Interim Safety Data Analysis of Intracept in SMART Pivotal Study and Expands Senior Leadership Team
7. Armada Health Care Achieves Full URAC Accreditation
8. Instrumentation Laboratory Achieves Record Sales In 2012
9. Echo Therapeutics Achieves ISO 13485 Certification
10. First Product in Tris Pharmas Collaboration with Vernalis Achieves Proof-of-Concept, Triggering Milestone Payment to Tris
11. Receptos Determines Novel GPCR Structure, Achieves Key Milestone in Collaboration with Ono Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/8/2017)... 2017   Responding to Heath Ledger,s father,s ... of singer Chris Cornell in May, the mental ... a free online psychiatric drug side effects ... about psychotropic drug risks. The father of ... an accidental overdose, has called for tighter rules on prescription ...
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
Breaking Medicine Technology:
(Date:6/28/2017)... OH (PRWEB) , ... June 28, 2017 , ... ... financial consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is teaming ... provide temporary lodgings for families with children receiving treatment in nearby hospitals. , ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... DrugDev ... study is whether they can trust the sponsor to pay them correctly and on ... sponsors and CROs establish payment strategies that encourage sites to work on their studies. ...
(Date:6/27/2017)... ... ... The Congressional Budget Office (CBO) projects that the Better Care Reconciliation Act (BCRA), ... Care Act (ACA), would result in 22 million Americans losing their health insurance by ... 20 million Americans have gained health insurance under the ACA, and from 2013 to ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... A January ... been projected to reach a staggering $6.81 billion by the year 2024 according to ... at a faster rate than those made from titanium. Los Angeles area clinic Beverly ...
(Date:6/27/2017)... New York, NY (PRWEB) , ... June 27, ... ... communications and marketing experts to contribute to an upcoming case studies guidebook. This ... or her organization. , This book will include articles, case studies and how-to’s ...
Breaking Medicine News(10 mins):